Two research teams have developed noninvasive tests that use blood or saliva samples to diagnose cases of colorectal cancer and prostate cancer.
Lab
The global direct-to-consumer lab test market is predicted to see 26 percent compound annual growth through 2031, according to a report by Albany, N.Y.-based Transparency Market Research. The growth will likely far outpace that of the overall clinical lab test…
Welsh point-of-care testing company EKF Diagnostics is acquiring San Antonio-based Advanced Diagnostics Laboratory for $10 million in shares and additional performance-based payments of up to $60 million, the company said Sept. 29.
A new rapid test identifies severe COVID-19 patients more accurately than existing tests, researchers said Sept. 29 at the 2021 AACC Annual Scientific Meeting and Clinical Lab Expo in Atlanta.
Rockville, Md.-based lab testing company 20/20 GeneSystems has launched a shared lab to help diagnostic test makers cut the time and cost of launching their tests in the U.S., the company said Sept. 28.
Advertisement
Healthy patients undergoing lab testing before surgery is one of the most common forms of unnecessary, low-value care, according to a study published Sept. 27 in JAMA Internal Medicine.
Canadian medical lab firm Empower Clinics, parent company of Dallas-based Kai Medical Lab, is partnering with Canadian cybersecurity company SoLVBL Solutions to provide data security to the diagnostic testing programs Empower uses, the company said Sept. 27.
Maywood, Ill.-based Loyola Medicine has opened a 30,000-square-foot clinical lab on its main medical center campus, according to commercial real estate outlet REBusiness Online.
The market for lab-developed tests, now worth $4.5 billion globally, is expected to see 7 percent compound annual growth through 2028, according to a new Research and Markets report.
Spanish startup Mecwins is developing in vitro diagnostic testing lab technology that detects concentrations in femtograms per milliliter — 1,000 times more sensitive than widely available enzyme-linked immunosorbent assays, the company said Sept. 24.